cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.14457/tu.the.2020.908
title: การศึกษาอิทธิพลขององค์ประกอบในการออกแบบภายในบ้านตัวอย่างต่อการตัดสินใจซื้อที่อยู่อาศัยในโครงการหมู่บ้านจัดสรรในเขตกรุงเทพมหานครและปริมณฑลด้วยการวิเคราะห์เชิงลำดับชั้นแบบประยุกต์

description: บ้านตัวอย่างเป็นเครื่องมือสำคัญในการนำเสนอสินค้าของผู้ประกอบการ โดยการสร้างความรู้สึก สร้างแรงจูงใจ สร้างจินตนาการ และความเข้าใจในสินค้า เพื่อกระตุ้นให้เกิดการตัดสินใจซื้อ งานวิจัยนี้มีวัตถุประสงค์เพื่อศึกษาระดับอิทธิพลขององค์ประกอบในงานออกแบบภายในบ้านตัวอย่างต่อการตัดสินใจซื้อที่อยู่อาศัย โดยเก็บข้อมูลจากการทบทวนวรรณกรรมและจากการสัมภาษณ์เชิงลึกเพื่อสอบถามความเห็นจากผู้เชี่ยวชาญจำนวน 5 ท่าน ซึ่งเป็นผู้มีประสบการณ์ในการออกแบบภายในบ้านตัวอย่างของโครงการหมู่บ้านจัดสรรมาแล้วไม่น้อยกว่า 5 โครงการ จากนั้นนำข้อมูลที่ได้ไปสร้างแบบสอบถามผู้บริโภค 405 ท่าน ซึ่งเป็นผู้ที่มีส่วนร่วมในการตัดสินใจซื้อที่อยู่อาศัยในโครงการหมู่บ้านจัดสรรประเภท บ้านเดี่ยว บ้านแฝดและทาวน์เฮ้าส์ ระดับราคาไม่เกิน 3.00 ล้านบาทจนถึง ระดับราคาสูงกว่า 10.00 ล้านบาท และนำผลที่ได้มาทำการวิเคราะห์ผลโดยการคำนวณค่าน้ำหนักด้วยกระบวนการลำดับเชิงวิเคราะห์แบบประยุกต์ (Modified Analytic Hierarchy Process : Modified AHP) และการวิเคราะห์เนื้อหา (Content Analysis) ผลงานวิจัยแสดงองค์ประกอบในการออกแบบภายในบ้านตัวอย่างและค่าอิทธิพลต่อการตัดสินใจซื้อที่อยู่อาศัยตลอดจนลักษณะขององค์ประกอบในการออกแบบภายในบ้านตัวอย่างที่มีผลต่อการตัดสินใจซื้อที่อยู่อาศัยประเภทบ้านเดี่ยว บ้านแฝดและทาวน์เฮาส์ ผลการศึกษาพบว่า กลุ่มตัวอย่างที่ต้องการซื้อที่อยู่อาศัยที่ประเภทและระดับราคาต่างกัน ให้ความสำคัญต่อปัจจัยและองค์ประกอบในการออกแบบภายในที่ต่างกัน โดยที่อยู่อาศัยทั้ง 3 ประเภทที่ระดับราคาที่สูงกว่า 10.01 ล้านบาท กลุ่มตัวอย่างให้ความสำคัญกับปัจจัยด้านพื้นที่ใช้สอยภายในสูงที่สุดเหมือนกัน โดยผู้ซื้อบ้านเดี่ยวให้ความสำคัญกับองค์ประกอบเรื่องฮวงจุ้ย ส่วนผู้ซื้อบ้านแฝดและทาวน์เฮ้าส์ให้ความสำคัญกับการจัดพื้นที่ใช้สอยภายใน นอกจากนี้ผู้ออกแบบจะให้ความสำคัญกับองค์ประกอบด้านแนวคิดในการออกแบบ (Design Concept) เป็นลำดับแรก แต่ในมุมของกลุ่มตัวอย่างจะมองจากสิ่งที่สามารถรับรู้ สัมผัสได้ด้วยตา และส่งผลต่อความรู้สึก ทำให้สามารถสื่อสารออกมาได้ง่าย เช่น สวย ทันสมัย พื้นที่ใช้สอยดี
DOI: 10.5281/zenodo.5910434
title: Is SF-12 a valid and reliable measurement of health-related quality of life among adults with Marfan syndrome? A confirmatory study

description: Dataset from Udugampolage N, Caruso R, Panetta M, Callus E, Dellafiore F, Magon A, Marelli S, Pini A. Is SF-12 a valid and reliable measurement of health-related quality of life among adults with Marfan syndrome? A confirmatory study. PLoS One. 2021 Jun 9;16(6):e0252864. doi: 10.1371/journal.pone.0252864. PMID: 34106976; PMCID: PMC8189474. Abstract <strong>Introduction: </strong>The structural validity and reliability of the Short-Form Health Survey 12 (SF-12) has not yet been tested in adults with the Marfan syndrome (MFS). This gap could undermine an evidence-grounded practice and research, especially considering that the need to assess health-related quality of life in patients with MFS has increased due to the improved life expectancy of these patients and the need to identify their determinants of quality of life. For this reason, this study aimed to confirm the dimensionality (structural validity) of the SF-12, its concurrent validity, and its reliability (internal consistency). <strong>Methods: </strong>We performed a cross-sectional study in a convenience sample of 111 Italian adults with MFS, collecting anamnestic and socio-demographic information, the SF-12, and short-form Health Survey 36 (SF-36). A confirmatory factor analysis was performed to verify whether the items of SF-12 related to physical restrictions, physical functioning, and bodily pain were retained by the physical summary component of the SF-12. The items referred to the role limitations due to emotional issues, social functioning, and mental health were retained by the mental summary component (MCS12). SF-36 was used to assess the concurrent validity of SF-12, hypothesizing positive correlations among the equivalent summary scores. <strong>Results: </strong>The two-factor structural solution resulted in fitting the sample statistics adequately. The internal consistency was adequate for the two factors. Furthermore, the physical and mental summary scores of the SF-36 were positively correlated with their equivalent summary scores derived from the SF-12. <strong>Conclusions: </strong>This study confirmed the factor structure of the SF-12. Therefore, the use of SF-12 in clinical practice and research for assessing the health-related quality of life among adults with MFS is evidence-grounded. Future research is recommended to determine whether the SF-12 shows measurement invariance in different national contexts and determine eventual demographic variation in the SF-12 scores among patients with MFS.
DOI: 10.5281/zenodo.5910433
title: Is SF-12 a valid and reliable measurement of health-related quality of life among adults with Marfan syndrome? A confirmatory study

description: Dataset from Udugampolage N, Caruso R, Panetta M, Callus E, Dellafiore F, Magon A, Marelli S, Pini A. Is SF-12 a valid and reliable measurement of health-related quality of life among adults with Marfan syndrome? A confirmatory study. PLoS One. 2021 Jun 9;16(6):e0252864. doi: 10.1371/journal.pone.0252864. PMID: 34106976; PMCID: PMC8189474. Abstract <strong>Introduction: </strong>The structural validity and reliability of the Short-Form Health Survey 12 (SF-12) has not yet been tested in adults with the Marfan syndrome (MFS). This gap could undermine an evidence-grounded practice and research, especially considering that the need to assess health-related quality of life in patients with MFS has increased due to the improved life expectancy of these patients and the need to identify their determinants of quality of life. For this reason, this study aimed to confirm the dimensionality (structural validity) of the SF-12, its concurrent validity, and its reliability (internal consistency). <strong>Methods: </strong>We performed a cross-sectional study in a convenience sample of 111 Italian adults with MFS, collecting anamnestic and socio-demographic information, the SF-12, and short-form Health Survey 36 (SF-36). A confirmatory factor analysis was performed to verify whether the items of SF-12 related to physical restrictions, physical functioning, and bodily pain were retained by the physical summary component of the SF-12. The items referred to the role limitations due to emotional issues, social functioning, and mental health were retained by the mental summary component (MCS12). SF-36 was used to assess the concurrent validity of SF-12, hypothesizing positive correlations among the equivalent summary scores. <strong>Results: </strong>The two-factor structural solution resulted in fitting the sample statistics adequately. The internal consistency was adequate for the two factors. Furthermore, the physical and mental summary scores of the SF-36 were positively correlated with their equivalent summary scores derived from the SF-12. <strong>Conclusions: </strong>This study confirmed the factor structure of the SF-12. Therefore, the use of SF-12 in clinical practice and research for assessing the health-related quality of life among adults with MFS is evidence-grounded. Future research is recommended to determine whether the SF-12 shows measurement invariance in different national contexts and determine eventual demographic variation in the SF-12 scores among patients with MFS.
DOI: 10.6084/m9.figshare.16652012
title: Study of patient characteristics, treatment patterns, <i>EGFR</i> testing patterns and outcomes in real-world patients with <i>EGFR</i>m<sup>+</sup> non-small cell lung cancer

description: This retrospective, observational study examined patient characteristics, treatment patterns, testing patterns, and outcomes of US patients receiving first-/second- or third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). This study used an electronic health record-derived de-identified database. Eligible patients had advanced <i>EGFR</i>m<sup>+</sup> non-small cell lung cancer. Descriptive statistics were used to describe demographic, clinical, and treatment characteristics. Logistic regression models were used to identify patient characteristics that were associated with the use of osimertinib vs. a first-/second-generation EGFR TKI. Kaplan–Meier methods were used for survival analysis. Of the 782 patients who received first-line (1L) therapy with first-/second-generation EGFR TKIs in cohort A, erlotinib was the most common (58%), and osimertinib was the most widely prescribed second-line (2L) therapy (52%). Of the patients who received 1L therapy with osimertinib, a greater range of treatments were prescribed in 2L. A third of patients treated with first-/second-generation EGFR TKIs underwent <i>EGFR</i> testing near the end of 1L, and 44% of these patients had T790M positive disease. The median time on targeted therapy (TTT) of the cohort was 11.1 months (95% confidence interval [CI] 9.7, 12.3), and the median overall survival from the start of 1L therapy was 23.5 months (95% CI 20.7, 24.8). The majority of patients treated with first-/second-generation EGFR TKIs went on to receive osimertinib in the 2L setting, but overall, only a third of patients had received molecular testing at progression. Improved testing frequency is vital to inform treatment decisions.
DOI: 10.6084/m9.figshare.16867321.v1
title: Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review

description: Globally, pharmacovigilance (PV) is crucial for the patient’s safety and proper use of drugs. Spontaneous reporting of adverse drug reaction (ADR) is a professional obligation of every healthcare professionals (HCPs). The purpose of this systematic review was to analyze the existing literature about the knowledge, attitude, and practices (KAP) level of HCPs regarding PV and ADRs reporting in Turkey. A systematic and comprehensive articles search strategy was carried out in different seven electronic databases (PubMed, PubMed Central, Goggle Scholar, Ovid-SP, MEDLINE, Wiley Online Library, DergiPark) from 2010 to 2020. We searched to identify existing literature about cross-sectional observational studies investigating the KAP of HCPs regarding PV and ADRs reporting in different geographical regions of Turkey. Quality assessment and risk of bias were assessed among included studies. Fifteen studies were chosen for full-text analysis. Finally, according to inclusion criteria, seven research articles were selected for systematic review. Overall, the KAP of HCPs varies across the studies. The lack of a standardized validated measuring tool to evaluate the KAP and differences in questionnaire items were the main limitations in included studies. Around, 69.1% (range: 54.6–100%) of HCPs were not aware of the national pharmacovigilance center in Turkey. About, 37.5% (range: 7.1–75.7%) of HCPs believed that reporting of ADRs is not important and 87.5% (range: 69.3–100%) stated that they never reported ADR previously during their practice. The most frequently highlighted barriers to PV were lack of time, uncertainty and did not know where to report. This systematic review revealed a major KAP gap in Turkey towards PV activities. Low ADR reporting practice of HCPs was a major identified issue. The creation of a mandatory unified PV education intervention for future HCPs to rationally report ADR of drugs are crucial for a better healthcare system.
DOI: 10.6084/m9.figshare.16652012.v2
title: Study of patient characteristics, treatment patterns, <i>EGFR</i> testing patterns and outcomes in real-world patients with <i>EGFR</i>m<sup>+</sup> non-small cell lung cancer

description: This retrospective, observational study examined patient characteristics, treatment patterns, testing patterns, and outcomes of US patients receiving first-/second- or third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). This study used an electronic health record-derived de-identified database. Eligible patients had advanced <i>EGFR</i>m<sup>+</sup> non-small cell lung cancer. Descriptive statistics were used to describe demographic, clinical, and treatment characteristics. Logistic regression models were used to identify patient characteristics that were associated with the use of osimertinib vs. a first-/second-generation EGFR TKI. Kaplan–Meier methods were used for survival analysis. Of the 782 patients who received first-line (1L) therapy with first-/second-generation EGFR TKIs in cohort A, erlotinib was the most common (58%), and osimertinib was the most widely prescribed second-line (2L) therapy (52%). Of the patients who received 1L therapy with osimertinib, a greater range of treatments were prescribed in 2L. A third of patients treated with first-/second-generation EGFR TKIs underwent <i>EGFR</i> testing near the end of 1L, and 44% of these patients had T790M positive disease. The median time on targeted therapy (TTT) of the cohort was 11.1 months (95% confidence interval [CI] 9.7, 12.3), and the median overall survival from the start of 1L therapy was 23.5 months (95% CI 20.7, 24.8). The majority of patients treated with first-/second-generation EGFR TKIs went on to receive osimertinib in the 2L setting, but overall, only a third of patients had received molecular testing at progression. Improved testing frequency is vital to inform treatment decisions.
DOI: 10.6084/m9.figshare.16867321
title: Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review

description: Globally, pharmacovigilance (PV) is crucial for the patient’s safety and proper use of drugs. Spontaneous reporting of adverse drug reaction (ADR) is a professional obligation of every healthcare professionals (HCPs). The purpose of this systematic review was to analyze the existing literature about the knowledge, attitude, and practices (KAP) level of HCPs regarding PV and ADRs reporting in Turkey. A systematic and comprehensive articles search strategy was carried out in different seven electronic databases (PubMed, PubMed Central, Goggle Scholar, Ovid-SP, MEDLINE, Wiley Online Library, DergiPark) from 2010 to 2020. We searched to identify existing literature about cross-sectional observational studies investigating the KAP of HCPs regarding PV and ADRs reporting in different geographical regions of Turkey. Quality assessment and risk of bias were assessed among included studies. Fifteen studies were chosen for full-text analysis. Finally, according to inclusion criteria, seven research articles were selected for systematic review. Overall, the KAP of HCPs varies across the studies. The lack of a standardized validated measuring tool to evaluate the KAP and differences in questionnaire items were the main limitations in included studies. Around, 69.1% (range: 54.6–100%) of HCPs were not aware of the national pharmacovigilance center in Turkey. About, 37.5% (range: 7.1–75.7%) of HCPs believed that reporting of ADRs is not important and 87.5% (range: 69.3–100%) stated that they never reported ADR previously during their practice. The most frequently highlighted barriers to PV were lack of time, uncertainty and did not know where to report. This systematic review revealed a major KAP gap in Turkey towards PV activities. Low ADR reporting practice of HCPs was a major identified issue. The creation of a mandatory unified PV education intervention for future HCPs to rationally report ADR of drugs are crucial for a better healthcare system.
DOI: 10.6084/m9.figshare.16652012.v1
title: Study of patient characteristics, treatment patterns, <i>EGFR</i> testing patterns and outcomes in real-world patients with <i>EGFR</i>m<sup>+</sup> non-small cell lung cancer

description: This retrospective, observational study examined patient characteristics, treatment patterns, testing patterns and outcomes of US patients receiving first-/second- or third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). This study used an electronic health record–derived de-identified database. Eligible patients had advanced <i>EGFR</i>m<sup>+</sup> non-small cell lung cancer. Descriptive statistics were used to describe demographic, clinical and treatment characteristics. Logistic regression models were used to identify patient characteristics that were associated with the use of osimertinib vs. a first-/second-generation EGFR TKI. Kaplan-Meier methods were used for survival analysis. Of the 782 patients who received first-line (1L) therapy with first-/second-generation EGFR TKIs in the cohort A, erlotinib was the most common (58%), and osimertinib was the most widely prescribed second-line (2L) therapy (52%). Of the patients who received 1L therapy with osimertinib, a greater range of treatments were prescribed in 2L. A third of patients treated with first-/second-generation EGFR TKIs underwent <i>EGFR</i> testing near the end of 1L, and 44% of these patients had T790M positive disease. The median time on targeted therapy (TTT) of the cohort was 11.1 months (95% confidence interval [CI] 9.7, 12.3) and the median overall survival from the start of 1L therapy was 23.5 months (95% CI 20.7, 24.8). The majority of patients treated with first-/second-generation EGFR TKIs went on to receive osimertinib in the 2L setting, but overall, only a third of patients had received molecular testing at progression. Improved testing frequency is vital to inform treatment decisions.
DOI: 10.6084/m9.figshare.17307074.v2
title: Prevalence of Depressive Symptoms in Patients with Chronic Physical Illness

description: This cross-sectional analytical study was conducted among the patients receiving outpatient and inpatient services for chronic medical illnesses of Shree Birendra Hospital, a tertiary-level hospital. Data for the analysis was collected over four months (February - May 2021). After reviewing the hospital annual record sheet, patients diagnosed with Hypertension, DM, COPD, CKD, and Congestive Heart Disease (CHD) (the five most prevalent chronic illnesses) were included. The cases diagnosed by the treating physician of Shree Birendra Hospital and receiving medication for at least a year who could respond/ express well and give consent were eligible for participation. The patients too unwell to participate were excluded from the study.Demographic and socio-economic variables such as Gender (male/ female), residence (rural/urban), Education (Illiterate/ Literate/ Primary/ Secondary/ Higher secondary), marital status (Married/ widow/ widower), Religion (Hindu/ Buddhist/ Christian/ Others), Kuppuswamy’s score (Upper middle/ Middle-Lower middle/ Lower-Upper Lower/ Lower), physical activity (Sedentary/ Non Sedentary), sleep (Adequate/ Inadequate), substance abuse (Alcohol/ Smoking/ Both/ None/ Missing), comorbidities (Hypertension/DM/COPD/CKD/CHD/ Multiple), duration of illness (1-5 years/ 6-10 years/ 11 and above), past history of depression (Yes/ No) were included in the survey questionnaire <br><br>
DOI: 10.6084/m9.figshare.18978428
title: Dataset: Intra-Company Crowdsensing: Datafication with Human-in-the-Loop.

description: <b>Intra-Company Crowdsensing: Datafication with Human-in-the-Loop </b>(Dataset).<b><br></b><b>Abstract: </b>Every day employees learn about things happening in their company. This includes plain facts witnessed while on the job, related or not to one’s job responsibilities. Many of these facts, which we call “occurrence data,”, are known by employees but remain unknown to the company. We suppose that some of them are valuable and may improve the company’s situational awareness. In the spirit of mobile crowdsensing, we propose intra-company crowdsensing (ICC), a method to of “extracting” occurrence data from employees. In ICC, an employee occasionally responds to sensing requests, each about one plain fact. We elaborate the concept of ICC, proposing a model of human-system interaction, a system architecture, and an organizational process. We position ICC with respect to related concepts from information technology, and we look at it from selected organizational and managerial viewpoints. Finally, we conducted a survey, in which we presented the concept of ICC to employees of different companies and asked for their evaluation. Respondents positive about ICC outnumbered skeptics by a wide margin. The survey also revealsed some concerns, mostly related to ICC being perceived as another employee surveillance tool. However, useful and acceptable sensing requests are likely to be found in every organization.<br>--------------------------<b>Online Questionnaire</b> The survey was conducted as a computer-assisted web interview (CAWI). We started with a short pilot phase and noticed that a number of pilot respondents had mistakenly understood that ICC covered not just plain facts, but also opinions or interpretations. To avoid the confusion, we explained the concept more clearly in the introduction to the questionnaire and added reminders to some of its questions. It took about fifteen minutes to complete the revised questionnaire. We used non-probabilistic, convenience sampling. An invitation to the survey was distributed via the newsletter of the Centre for Innovation and Technology Transfer Management at Warsaw University of Technology as well as via social media. We stressed that we were seeking respondents with work experience.------------------------<br>
DOI: 10.5281/zenodo.5801272
title: Coded data and R scripts for the article-Toward a dynamic behavioral profile of the Mandarin Chinese temperature term re

description: These are the coded dataset and R scripts for the article "Towards a dynamic behavioral profile of Mandarin Chinese temperature term re: A diachronic semasiological approach".
DOI: 10.6084/m9.figshare.19032668
title: Prevalence of depressive symptoms in patients with chronic physical illness: A single institutional cross-sectional study from Nepal

description: This is spss data of depression with socio-demographic and clinical variableand the questionnaire used for data collection along with consent form
DOI: 10.6084/m9.figshare.19032668.v3
title: Prevalence of depressive symptoms in patients with chronic physical illness: A single institutional cross-sectional study from Nepal

description: This is spss data of depression with socio-demographic and clinical variableand the questionnaire used for data collection along with consent form
DOI: 10.6084/m9.figshare.19032668.v2
title: Prevalence of depressive symptoms in patients with chronic physical illness: A single institutional cross-sectional study from Nepal

description: This is spss data of depression with socio-demographic and clinical variableand the questionnaire used for data collection along with consent form
DOI: 10.34740/kaggle/dsv/3101191
title: YouTube Trending Video Dataset (updated daily)
DOI: 10.25403/upresearchdata.19029833
title: Examining factors influencing tourism levy collection in Gauteng graded accommodation establishments

description: Quantitative dataset on the factors affecting tourism revenue collection. Examining factors influencing tourism levy collection in Gauteng graded accommodation establishments. Quantitative method was employed. The results are quantitative in nature. Title of the thesis: the effectiveness of the tourism levy administration on revenue collection in Gauteng graded accommodation establishments.<br>
DOI: 10.25403/upresearchdata.19029833.v2
title: Examining factors influencing tourism levy collection in Gauteng graded accommodation establishments

description: Quantitative dataset on the factors affecting tourism revenue collection. Examining factors influencing tourism levy collection in Gauteng graded accommodation establishments. Quantitative method was employed. The results are quantitative in nature. Title of the thesis: the effectiveness of the tourism levy administration on revenue collection in Gauteng graded accommodation establishments.<br>